The United States Food and Drug Administration has granted approval for Jideytro, (zidesamtinib), as a targeted therapy for adult patients facing locally advanced or metastatic ROS1 positive non small cell lung cancer. This clearance applies specifically to individuals who have already undergone treatment with a prior ROS1 kinase inhibitor. Regulatory authorization arrived ahead of the anticipated September deadline following prior Breakthrough Therapy and Orphan Drug recogni

Top 10 healthcare companies by revenues | 2026 Rank Company Q1 H1 9M 2026 revenues 1 United Health Group $111.7 $223.7 2 CVS Health $100.4 3 Cigna Group $68.5 4 Centene $49.9 5 Elevance Health $49.5 $99.3 6 Humana $39.6 7 Kaiser Permanente $34.6 8 HCA Healthcare $19.1 9 HCSC $16.6 10 Molina Healthcare $10.8 $20.4 Top Healthcare Companies by Revenues | 2026 United Health Group Q1 REVENUES: UnitedHealth Group reported first-quarter 2026 revenues of $111.7 billion, representing